Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema

• Status: Unknown status
• Trial end date: 2007-02-01
• Target enrollment: 0
• Participant gender: All

Summary

to compare the effect of intravitreal bevacizumab alone or in combination with triamcinolone acetonide with laser photocoagulation on clinically significant macular edema (CSME)

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shahid Beheshti University of Medical Sciences
• Treatments: Bevacizumab; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• case with clear media IOP below 23 mm/Hg female after menopause at least for 12 months or had 2 contraceptive roots visual acuity between 20/50 to 20/320

Exclusion Criteria:

• no PRP or N.d YAG laser in past 6 months no intraocular surgery in past 12 months

• CVA in past 12 months blood sugar above 250

• active infection in extraocular adnexa